A unique collection of xnum stem cell differentiation signaling targeted compounds for high throughput and high content screening;

A unique collection of xnum cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum cancer cell differentiation inducing compounds for high throughput and high content screening;

A unique collection of xnum cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of xnum neurotransmitter receptor compounds, can be used for HTS and HCS screening；

A unique collection of xnum compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A collection of xnum small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of xnum anti-obesity compounds for high throughput and high content screening;

A unique collection of xnum gut microbial metabolites which can be used for HTS and HCS;

A unique collection of xnum pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;

A unique collection of xnum approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum flavonoids can be used for high throughput and high content screening；

A unique collection of xnum compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A unique collection of xnum natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

xnum compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；

A unique collection of xnum compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；

A unique collection of xnum compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；

A unique collection of xnum compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A collection of xnum bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

Well-chosen xnum compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of xnum compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);

xnum glycometabolism-related comounds, can be used for HTS and HCT;

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of xnum small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of xnum compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;

xnum Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

A unique collection of xnum beta-lactam compounds, can be used in HTS and HCS;

A unique collection of xnum ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study；

Well-chosen xnum GPCR targeting compounds with unique structures;

xnum tumor-targeted drugs that can be used for high-throughput and high-content screening.

A collection of xnum TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；

A unique collection of xnum microtubule-targeted compounds can be used in HTS and HCS;

A unique collection of xnum sodium channel blockers and agonists for high throughput and high content screening;

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

A unique collection of xnum compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;

A unique collection of xnum kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of xnum apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;

A unique collection of xnum anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum cytoskeleton-related compounds, can be used for HTS and HCS；

A unique collection of xnum glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;

A unique collection of xnum reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.

A unique collection of xnum TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;

A unique collection of xnum compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of xnum Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;

A unique collection of xnum rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);